EVALOSE Drug Patent Profile
✉ Email this page to a colleague
When do Evalose patents expire, and when can generic versions of Evalose launch?
Evalose is a drug marketed by Teva Pharms and is included in one NDA.
The generic ingredient in EVALOSE is lactulose. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Evalose
A generic version of EVALOSE was approved as lactulose by HIKMA on July 3rd, 1995.
Summary for EVALOSE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 3 |
Patent Applications: | 119 |
Formulation / Manufacturing: | see details |
DailyMed Link: | EVALOSE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for EVALOSE
US Patents and Regulatory Information for EVALOSE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Pharms | EVALOSE | lactulose | SOLUTION;ORAL | 073497-001 | May 28, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |